Safety profile and medium- to long-term protection of the Recombinant Zoster vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021-2025 [0.03%]
重组带状疱疹疫苗(RZV)在高危患者人群中的安全性和中至长期保护效果：2021-2025年意大利南部一家综合医院的真实世界数据
Pasquale Stefanizzi,Lorenza Moscara,Claudia Palmieri et al.
Pasquale Stefanizzi et al.
Introduction: Recombinant Zoster Vaccine (RZV) is recommended for Herpes Zoster (HZ) prevention in high-risk patients over 18 years of age. Research desig...
Off-Label use of vaccines may save lives and money: lessons from the province of Quebec, Canada [0.03%]
越界使用疫苗可能节约生命和金钱——来自加拿大魁北克省的启示
Philippe De Wals,Caroline Quach
Philippe De Wals
Introduction: In Canada, vaccines are authorized by Health Canada but publicly funded programs are of provincial/territorial jurisdiction. Off-label (OL) use of vaccines has been frequently implemented in Quebec over the ...
Healthcare providers' preferences for pediatric pneumococcal vaccination recommendations in the United States [0.03%]
美国儿科肺炎球菌疫苗接种指南的医疗提供者偏好
Jeffrey Vietri,Kelley Myers,Liping Huang et al.
Jeffrey Vietri et al.
Background: A 20-valent pneumococcal conjugate vaccine (PCV20) was recently licensed for use in children by the United States Food and Drug Administration. The objective of this study was to assess healthcare providers' (...
Correction [0.03%]
改正
Published Erratum
Expert review of vaccines. 2025 Dec;24(1):991. DOI:10.1080/14760584.2025.2588050 2025
Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain [0.03%]
西班牙2023/24年度冬季和夏季COVID-19疫情中秋季加强剂疫苗的有效性
Ayelén Rojas-Benedicto,Gloria Pérez-Gimeno,Jacobo Mendioroz et al.
Ayelén Rojas-Benedicto et al.
Background: We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ≥60-year-olds against medically-attended COVID-19 and COVID-19 hospitalization, duri...
Birth order and influenza vaccination: a comparative study of behaviors and intentions between first-time and second-time Chinese parents [0.03%]
独生与非独生中国父母的流感疫苗接种行为和意愿之比较研究
Kan Chen,Zhexin Xu,Yi Zhou et al.
Kan Chen et al.
Background: This study investigates the impact of birth order on influenza vaccination behaviors and intentions among parents of children under 6 years of age, and identifies factors contributing to vaccination disparitie...
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy [0.03%]
新型癌症免疫治疗疫苗佐剂Montanide ISA-51研究进展
Liu Nan,Xiuli Zhang,Li Ziyi et al.
Liu Nan et al.
Introduction: Cancer vaccine immunotherapy has shifted from traditional cytotoxic treatments toward strategies aimed at enhancing anti-tumor immunity, offering new therapeutic possibilities. Montanide ISA-51, a water-in-o...
Correction [0.03%]
改正的方法
Published Erratum
Expert review of vaccines. 2025 Dec;24(1):944. DOI:10.1080/14760584.2025.2567718 2025
Correction [0.03%]
改正措施
Published Erratum
Expert review of vaccines. 2025 Dec;24(1):945. DOI:10.1080/14760584.2025.2567720 2025
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2 + 1 schedule [0.03%]
使用2+1免疫程序在儿童中对15价和20价肺炎球菌结合疫苗进行免疫原性间接比较研究
Shahrul Mt-Isa,Justin R Chumbley,Matthew S Kelly et al.
Shahrul Mt-Isa et al.
Background: Clinical trials have compared new pneumococcal conjugative vaccines (PCVs; PCV15 and PCV20) to an established PCV (PCV13) in a routine 2 + 1 schedule. This study performed an indirect comparison of PCV15 vs. P...